Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 166

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death

Open access
Li, Sainan, Li, Jingjing, Dai, Weiqi, Zhang, Qinghui, Feng, Jiao, Wu, Liwei, Liu, Tong, Yu, Qiang, Xu, Shizan, Wang, Wenwen, Lu, Xiya, Chen, Kan, Xia, Yujing, Lu, Jie, Zhou, Yingqun, Fan, Xiaoming, Mo, Wenhui, Xu, Ling, Guo, Chuanyong·2017·British Journal of Cancer

Abstract

BACKGROUND: Genistein is a natural isoflavone with many health benefits, including antitumour effects. Increased hypoxia-inducible factor 1 α (HIF-1α) levels and glycolysis in tumour cells are associated with an increased risk of mortality, cancer progression, and resistance to therapy. However, the effect of genistein on HIF-1α and glycolysis in hepatocellular carcinoma (HCC) is still unclear. METHODS: Cell viability, apoptosis rate, lactate production, and glucose uptake were measured in HCC cell lines with genistein incubation. Lentivirus-expressed glucose transporter 1 (GLUT1) or/and hexokinase 2 (HK2) and siRNA of HIF-1α were used to test the direct target of genistein. Subcutaneous xenograft mouse models were used to measure in vivo efficacy of genistein and its combination with sorafenib. RESULTS: Genistein inhibited aerobic glycolysis and induced mitochondrial apoptosis in HCC cells. Neither inhibitors nor overexpression of HK2 or GLUTs enhance or alleviate this effect. Although stabiliser of HIF-1α reversed the effect of genistein, genistein no longer has effects on HIF-1α siRNA knockdown HCC cells. In addition, genistein enhanced the antitumour effect of sorafenib in sorafenib-resistant HCC cells and HCC-bearing mice. CONCLUSIONS: Genistein sensitised aerobic glycolytic HCC cells to apoptosis by directly downregulating HIF-1α, therefore inactivating GLUT1 and HK2 to suppress aerobic glycolysis. The inhibitory effect of genistein on tumour cell growth and glycolysis may help identify effective treatments for HCC patients at advanced stages.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/bjc.2017.323

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 166

Metadata

Authors
Li, S., Li, J., Dai, W., Zhang, Q., Feng, J., Wu, L., Liu, T., Yu, Q., Xu, S., Wang, W., Lu, X., Chen, K., Xia, Y., Lu, J., Zhou, Y., Fan, X., Mo, W., Xu, L., & Guo, C.
Venue
British Journal of Cancer
Published
2017-09-19
Volume
117
Issue
10
Pages
1518-1528
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W2754521784
Cited by
166
References
3
FWCI
4.01
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death. https://app.cochat.ai/papers/10.1038/bjc.2017.323
The paper
Li, S., Li, J., Dai, W., Zhang, Q., Feng, J., Wu, L., Liu, T., Yu, Q., Xu, S., Wang, W., Lu, X., Chen, K., Xia, Y., Lu, J., Zhou, Y., Fan, X., Mo, W., Xu, L., & Guo, C. (2017). Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death. British Journal of Cancer. https://doi.org/10.1038/bjc.2017.323

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.